Evidence map›Paper›PMID 34202719›Full record

ArticleMicroorganisms2021

Assessment of Evolutionary Relationships for Prioritization of Myxobacteria for Natural Product Discovery.

Andrew Ahearne, Hanan Albataineh, Scot E Dowd, D Cole Stevens

Abstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Biodiscovery ofMicrobial genomics · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Microorganisms · 2022
    Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Andrew AhearneDepartment of BioMolecular Sciences, School of Pharmacy, University of Mississippi, Oxford, MS 38677, USA.
Hanan AlbatainehDepartment of BioMolecular Sciences, School of Pharmacy, University of Mississippi, Oxford, MS 38677, USA.
Scot E DowdMR DNA, Molecular Research LP, Shallowater, TX 79363, USA.
D Cole StevensDepartment of BioMolecular Sciences, School of Pharmacy, University of Mississippi, Oxford, MS 38677, USA.ORCID 0000-0001-6668-9419

Funding

Tracking Glycosylation State with Fluorinated Glycosides ProbesP20GM130460 · NIGMS · UNIVERSITY OF MISSISSIPPI · PI Joshua S Sharp · 2020 to 2026
$17.9M
Myxobacterial predatory antimicrobial production in response to quorum sensing signal interceptionR15AI137996 · NIAID · UNIVERSITY OF MISSISSIPPI · PI STEVENS, DAVID COLE · 2019 to 2019
$422k
National Institute of Allergy and Infectious Diseases 1 R15 AI137996-01A1NIAID NIH HHS R15 AI137996NIGMS NIH HHS 1 P20 GM130460-01A1NIGMS NIH HHS P20 GM130460
6 · The paper itself

Abstract

Discoveries of novel myxobacteria have started to unveil the potentially vast phylogenetic diversity within the family Myxococcaceae and have brought about an updated approach to myxobacterial classification. While traditional approaches focused on morphology, 16S gene sequences, and biochemistry, modern methods including comparative genomics have provided a more thorough assessment of myxobacterial taxonomy. Herein, we utilize long-read genome sequencing for two myxobacteria previously classified as

Indexed as

Archangium sp.biosynthetic gene clustersCorallococcus sp.Melittangium sp.myxobacteriaMyxococcus sp.

Identifiers

PMID34202719
PMCPMC8307915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.